ESMO: European Society for Medical Oncology

1. FDA Approves Apalutamide for Metastatic Castration-Sensitive Prostate Cancer

   Evidence for efficacy is based on the results from the TITAN trial

2. Simultaneous Review Decisions for Pembrolizumab Plus Lenvatinib in Australia, Canada and US

   Combination treatment concerns patients with advanced endometrial carcinoma who progressed on prior systemic treatment and whose tumours are not MSI-H or dMMR

3. Electronic Nose Can Sniff Out Which Lung Cancer Patients Will Respond to Immunotherapy [Annals of Oncology Press Release]

   An electronic nose that detects chemicals in the breath of lung cancer patients can identify with 85% accuracy those who will or will not respond to immunotherapy, according to new research published in the leading cancer journal Annals of Oncology today.

4. EMA Recommends Refusal of the Marketing Authorisation for Doxolipad

   Doxolipad, a hybrid medicine, contains the active substance doxorubicin

5. Horizon Europe 2021-2027

   The next research and innovation framework programme